Zhang et al. found that ROR inhibits expression of the cell proliferation inhibitory factor p53 by interacting with the RNA binding protein heterogeneous nuclear ribonucleoprotein I, and thereby promotes breast cancer proliferation [18]. Here, LINC-ROR is linked to breast carcinoma.